Email this article 
The experiment of using loratadinum in pregnant women with pruritic dermatoses
- Authors: Monakhov K.N.1, Kholodilova N.A.1
-
Affiliations:
- First Pavlov State Medical University of St. Petersburg
- Issue: Vol 92, No 3 (2016)
- Pages: 123-127
- Section: DRUG TREATMENT IN DERMATOVENEROLOGY
- Submitted: 24.08.2017
- Published: 24.06.2016
- URL: https://vestnikdv.ru/jour/article/view/249
- DOI: https://doi.org/10.25208/0042-4609-2016-92-3-123-127
- ID: 249
Cite item
Full Text
Abstract
Results of examination of 64 pregnant women with allergic dermatosis. Provides results of the efficacy, tolerance and safety study of the loratadinum drug in pregnant women with allergic dermatosis.
About the authors
K. N. Monakhov
First Pavlov State Medical University of St. Petersburg
Author for correspondence.
Email: noemail@neicon.ru
Россия
N. A. Kholodilova
First Pavlov State Medical University of St. Petersburg
Email: cholnatalex23@rambler.ru
Россия
References
- Pawankar R., Canonica G.W., Holgate S.T. et al. The World Allergy Orgamization White Book on Allergy (Update). 2013.
- Päunescu M.M., Feier V., Päunescu M. et al. Dermatoses of pregnancy. Acta Dermatovenerol Alp Panonica Adriat 2008; 17 (1): 4-11.
- Kemmett D. The influence of menstrual cycle and pregnancy on atopic dermatitis. D. Kemmett, M.J. Tidman. Br J Dermatol 1991; 125 (1): 59-61.
- Vaughan Jones S.A., Hern S., Nelson-Piercy C. et al. A prospective study of 200 women with dermatoses of pregnancy correlating clinical findings with hormonal and immunopathological profiles. Br J Dermatol 1999; 141 (1): 71-81
- Каширская Е.Н. Атопический дерматит и беременность (Особенности клиники, гормонально-метаболической перестройки, тактика ведения беременных как первичная профилактика атопического дерматита у детей): Автореф. дис. . канд. мед. наук. Екатеринбург, 1998
- Кочергин Н.Г. Особенности кожной патологии при беременности. Рос журн кож и венерич болезней 2002; 1: 33-36
- Hellerström S. Studies of Besnier’s prurigo (atopic dermatitis). S. Hellerström, H. Lidman. Acta Derm Venereol 1956; 36: 11-22
- Клиническая аллергология и иммунология. Руководство для практикующих врачей / под ред. Л.А. Горячкиной, К.П. Кашкина. М: Миклош 2011; 432
- Wojnarowska F. The skin in pregnancy. Oxford textbook of medicine: Fourth edition / ed. by D.A. Warell et al. Vol. 1. New York: Oxford Universisity Press, 2006.
- Kaiser H.B., Gopalan G., Chung W. Loratadine provides early symptom control in seasonal allergic rhinitis. Allergy Asthma Proc 2008; 29 (6): 654-8.
- Roman I.J., Kassem N., Gural R.P. et al. Suppression of histamine-induced wheal response by loratadine (SCH 29851) over 28 days in man. Ann Allergy 1986; 57: 253-6.
- Kâllén B. Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Fetal Neonatal Med 2002; 11 (3): 146-52.
- Moretti M.E., Caprara D., Coutinho C.J., Bar-Oz B., Berkovitch M., Addis A. et al. Fetal safety of loratadine use in the first trimester of preg nancy: a multicentre study. J Allergy Clin Immunol 2003; 111 (3): 479-83.
- Diav-Citrin O., Shechtman S., Aharonovich A., Moerman L., Arnon J., Wajnberg R. et al. Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled study. J Allergy Clin Immunol 2003; 111 (6): 1239-43.
- Kallen B., Olausson P.O. Monitoring of maternal drug use and infant congenital malforma tions. Does loratadine cause hypospadias? Int J Risk Saf Med 2001; 14: 115-9.
- So M., Bozzo P., Inoue M., Einarson A. Safety of antihistamines during pregnancy and lactation. Canadian Family Physician. 2010; 56: 427-9.
- Gilboa S.M., Strickland M.J., Olshan A.F., Werler M.M., Correa A., National Birth Defects Prevention Study. Use of antihistamine medications during early pregnancy and isolated major malformations. Birth Defects Res A Clin Mol Teratol 2009; 85 (2): 137-50.
- Schwarz E.B., Moretti M.E., Nayak S., Koren G. Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysis. Drug Saf 2008; 31 (9): 775-88.
Supplementary files
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).